Literature DB >> 31792580

[Drug-induced interstitial lung disease (DILD) during treatment with ustekinumab].

Constantin Sorger1, Jan Christoph Simon2, Regina Treudler2.   

Abstract

We report on a patient with severe psoriasis vulgaris who developed drug-induced interstitial lung disease (DILD) during treatment with ustekinumab. The diagnosis was based on coincidence with start of therapy, high-resolution computer tomography of the thorax and bronchoalveolar lavage. After discontinuation of the treatment with ustekinumab the clinical symptoms and the chest scan results improved. This case highlights a possible adverse event of ustekinumab.

Entities:  

Keywords:  Adverse effect; Drug-induced interstitial pneumonia; Interstitial pneumonia; Psoriasis; Pulmonary side effects

Mesh：

Substances：

Year:  2020        PMID： 31792580     DOI： 10.1007/s00105-019-04519-9

Source DB:  PubMed          Journal:  Hautarzt        ISSN： 0017-8470            Impact factor:   0.751


  9 in total

1.  Interstitial pneumonia in two patients with psoriasis during ustekinumab treatment.

Authors:  Sota Kikuchi; Yoshinori Umezawa; Mitsuha Hayashi; Koichi Yanaba; Osamu Fukuchi; Toshihiro Ito; Akihiko Asahina; Hidehisa Saeki; Hidemi Nakagawa
Journal:  J Dermatol       Date:  2015-12-24       Impact factor: 4.005

2.  A Case of Interstitial Lung Disease and Autoimmune Thyroiditis Associated with Ustekinumab.

Authors:  Seon Gu Lee; Ji Hae An; Dong Hyun Kim; Moon Soo Yoon; Hee Jung Lee
Journal:  Acta Derm Venereol       Date:  2019-03-01       Impact factor: 4.437

3.  [Ustekinumab-induced eosinophilic pneumonia during the course of ustekinumab therapy for plaque psoriasis].

Authors:  M Amy de la Bretèque; C Appere-De Vecchi; C Zeboulon; I Zaien; M-L Sigal; E Mahé
Journal:  Ann Dermatol Venereol       Date:  2015-01-23       Impact factor: 0.777

4.  Infliximab-induced nonspecific interstitial pneumonia.

Authors:  Soumitra Sen; Carrie Peltz; Kim Jordan; Thomas J Boes
Journal:  Am J Med Sci       Date:  2012-07       Impact factor: 2.378

Review 5.  The diagnosis and treatment of idiopathic pulmonary fibrosis.

Authors:  Jürgen Behr
Journal:  Dtsch Arztebl Int       Date:  2013-12-23       Impact factor: 5.594

6.  Respiratory failure due to infliximab induced interstitial lung disease.

Authors:  Sotiris Kakavas; Evangelos Balis; Vasiliki Lazarou; Marousa Kouvela; Georgios Tatsis
Journal:  Heart Lung       Date:  2013-08-19       Impact factor: 2.210

7.  Case of drug-induced interstitial lung disease secondary to adalimumab.

Authors:  Seema Alaee; Quentin Jones
Journal:  BMJ Case Rep       Date:  2018-05-15

8.  Interstitial Pneumonia in Psoriasis.

Authors:  Hironori Kawamoto; Hiromichi Hara; Shunsuke Minagawa; Takanori Numata; Jun Araya; Yumi Kaneko; Yoshinori Umezawa; Akihiko Asahina; Hidemi Nakagawa; Kazuyoshi Kuwano
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2018-09-20

9.  Ustekinumab Safety in Psoriasis, Psoriatic Arthritis, and Crohn's Disease: An Integrated Analysis of Phase II/III Clinical Development Programs.

Authors:  Subrata Ghosh; Lianne S Gensler; Zijiang Yang; Chris Gasink; Soumya D Chakravarty; Kamyar Farahi; Paraneedharan Ramachandran; Elyssa Ott; Bruce E Strober
Journal:  Drug Saf       Date:  2019-06       Impact factor: 5.606
  9 in total
  1 in total

1.  Characteristics of anti-IL-17/23 biologics-induced interstitial pneumonia in patients with psoriasis.

Authors:  Hanae Miyagawa; Hiromichi Hara; Jun Araya; Shunsuke Minagawa; Takanori Numata; Yoshinori Umezawa; Akihiko Asahina; Hidemi Nakagawa; Kazuyoshi Kuwano
Journal:  PLoS One       Date:  2021-01-07       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.